Dose optimisation and intensification of cytotoxics in solid tumours supported by haematopoietic growth factors.
Le Chevalier
T
T
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001943:Breast Neoplasms / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use*; D006801:Humans; D009503:Neutropenia / Q000517:prevention & control; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D016298:Hematopoietic Cell Growth Factors